Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPA

<p>Abstract</p> <p>Background</p> <p>Analysis of within-patient HIV evolution under anti-HIV therapy is crucial to a better understanding the possible mechanisms of HIV drug-resistance acquisition. The high evolutionary rate of HIV allows us to trace its evolutionary pr...

Full description

Bibliographic Details
Main Authors: Matsuda Masakazu, Shibata Junko, Sugiura Wataru, Hasegawa Naoki, Ren Fengrong, Tanaka Hiroshi
Format: Article
Language:English
Published: BMC 2009-10-01
Series:BMC Bioinformatics
Online Access:http://www.biomedcentral.com/1471-2105/10/360
_version_ 1811329404465315840
author Matsuda Masakazu
Shibata Junko
Sugiura Wataru
Hasegawa Naoki
Ren Fengrong
Tanaka Hiroshi
author_facet Matsuda Masakazu
Shibata Junko
Sugiura Wataru
Hasegawa Naoki
Ren Fengrong
Tanaka Hiroshi
author_sort Matsuda Masakazu
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Analysis of within-patient HIV evolution under anti-HIV therapy is crucial to a better understanding the possible mechanisms of HIV drug-resistance acquisition. The high evolutionary rate of HIV allows us to trace its evolutionary process in real time by analyzing virus samples serially collected from the same patient. However, such studies are still uncommon due to the lack of powerful computational methods designed for serial virus samples. In this study, we develop a computational method, vSPA (viral Sequential Pathway Analysis), which groups viral sequences from the same sampling time into clusters and traces the evolution between clusters over sampling times. The method makes use of information of different sampling times and traces the evolution of important amino acid mutations. Second, a permutation test at the codon level is conducted to determine the threshold of the correlation coefficient for clustering viral quasispecies. We applied vSPA to four large data sets of HIV-1 protease and reverse transcriptase genes serially collected from two AIDS patients undergoing anti-HIV therapy over several years.</p> <p>Results</p> <p>The results show that vSPA can trace within-patient HIV evolution by detecting many amino acid changes, including important drug-resistant mutations, and by classifying different viral quasispecies coexisting during different periods of the therapy.</p> <p>Conclusion</p> <p>Given that many new anti-HIV drugs will be available in the near future, vSPA may be useful for quickly providing information on the acquisition of HIV drug-resistant mutations by monitoring the within-patient HIV evolution under anti-HIV therapy as a computational approach.</p>
first_indexed 2024-04-13T15:43:18Z
format Article
id doaj.art-a107e38ca8064743b636128eb71c6bc0
institution Directory Open Access Journal
issn 1471-2105
language English
last_indexed 2024-04-13T15:43:18Z
publishDate 2009-10-01
publisher BMC
record_format Article
series BMC Bioinformatics
spelling doaj.art-a107e38ca8064743b636128eb71c6bc02022-12-22T02:41:05ZengBMCBMC Bioinformatics1471-21052009-10-0110136010.1186/1471-2105-10-360Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPAMatsuda MasakazuShibata JunkoSugiura WataruHasegawa NaokiRen FengrongTanaka Hiroshi<p>Abstract</p> <p>Background</p> <p>Analysis of within-patient HIV evolution under anti-HIV therapy is crucial to a better understanding the possible mechanisms of HIV drug-resistance acquisition. The high evolutionary rate of HIV allows us to trace its evolutionary process in real time by analyzing virus samples serially collected from the same patient. However, such studies are still uncommon due to the lack of powerful computational methods designed for serial virus samples. In this study, we develop a computational method, vSPA (viral Sequential Pathway Analysis), which groups viral sequences from the same sampling time into clusters and traces the evolution between clusters over sampling times. The method makes use of information of different sampling times and traces the evolution of important amino acid mutations. Second, a permutation test at the codon level is conducted to determine the threshold of the correlation coefficient for clustering viral quasispecies. We applied vSPA to four large data sets of HIV-1 protease and reverse transcriptase genes serially collected from two AIDS patients undergoing anti-HIV therapy over several years.</p> <p>Results</p> <p>The results show that vSPA can trace within-patient HIV evolution by detecting many amino acid changes, including important drug-resistant mutations, and by classifying different viral quasispecies coexisting during different periods of the therapy.</p> <p>Conclusion</p> <p>Given that many new anti-HIV drugs will be available in the near future, vSPA may be useful for quickly providing information on the acquisition of HIV drug-resistant mutations by monitoring the within-patient HIV evolution under anti-HIV therapy as a computational approach.</p>http://www.biomedcentral.com/1471-2105/10/360
spellingShingle Matsuda Masakazu
Shibata Junko
Sugiura Wataru
Hasegawa Naoki
Ren Fengrong
Tanaka Hiroshi
Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPA
BMC Bioinformatics
title Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPA
title_full Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPA
title_fullStr Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPA
title_full_unstemmed Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPA
title_short Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPA
title_sort inferring within patient hiv 1 evolutionary dynamics under anti hiv therapy using serial virus samples with vspa
url http://www.biomedcentral.com/1471-2105/10/360
work_keys_str_mv AT matsudamasakazu inferringwithinpatienthiv1evolutionarydynamicsunderantihivtherapyusingserialvirussampleswithvspa
AT shibatajunko inferringwithinpatienthiv1evolutionarydynamicsunderantihivtherapyusingserialvirussampleswithvspa
AT sugiurawataru inferringwithinpatienthiv1evolutionarydynamicsunderantihivtherapyusingserialvirussampleswithvspa
AT hasegawanaoki inferringwithinpatienthiv1evolutionarydynamicsunderantihivtherapyusingserialvirussampleswithvspa
AT renfengrong inferringwithinpatienthiv1evolutionarydynamicsunderantihivtherapyusingserialvirussampleswithvspa
AT tanakahiroshi inferringwithinpatienthiv1evolutionarydynamicsunderantihivtherapyusingserialvirussampleswithvspa